Literature DB >> 2999407

[[(4,5-Dihydro-2-oxazolyl)phenoxy]alkyl]isoxazoles. Inhibitors of picornavirus uncoating.

G D Diana, M A McKinlay, M J Otto, V Akullian, C Oglesby.   

Abstract

A series of [[(4,5-dihydro-2-oxazolyl)phenoxy]alkyl]isoxazoles has been synthesized and evaluated as antipicornavirus agents. The effect of alkyl groups in the 4- and 5-position of the oxazoline ring, as well as the alkyl chain length, on antiviral activity was examined. Compound 14 was evaluated in vivo and was found to significantly reduce mortality at an oral dose of 4 mg/kg in mice infected intracerebrally with poliovirus-2. Compound 14 was also effective in preventing paralysis when administered intraperitoneally to mice infected subcutaneously with a lethal dose of ECHO-9 virus. On the basis of the results of these studies, compound 14 is a strong candidate for clinical evaluation as a systemic agent for the treatment of picornavirus infections.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2999407     DOI: 10.1021/jm00150a025

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  18 in total

1.  Analysis of three structurally related antiviral compounds in complex with human rhinovirus 16.

Authors:  A T Hadfield; G D Diana; M G Rossmann
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

2.  Dissociation of an antiviral compound from the internal pocket of human rhinovirus 14 capsid.

Authors:  Yumin Li; Zhigang Zhou; Carol Beth Post
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-17       Impact factor: 11.205

Review 3.  Back to the future: Advances in development of broad-spectrum capsid-binding inhibitors of enteroviruses.

Authors:  Anna Egorova; Sean Ekins; Michaela Schmidtke; Vadim Makarov
Journal:  Eur J Med Chem       Date:  2019-06-11       Impact factor: 6.514

4.  Prevention of rhinovirus and poliovirus uncoating by WIN 51711, a new antiviral drug.

Authors:  M P Fox; M J Otto; M A McKinlay
Journal:  Antimicrob Agents Chemother       Date:  1986-07       Impact factor: 5.191

5.  Long-distance correlations of rhinovirus capsid dynamics contribute to uncoating and antiviral activity.

Authors:  Amitava Roy; Carol Beth Post
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-21       Impact factor: 11.205

6.  Structural analysis of a series of antiviral agents complexed with human rhinovirus 14.

Authors:  J Badger; I Minor; M J Kremer; M A Oliveira; T J Smith; J P Griffith; D M Guerin; S Krishnaswamy; M Luo; M G Rossmann
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

7.  Mutation in enterovirus 71 capsid protein VP1 confers resistance to the inhibitory effects of pyridyl imidazolidinone.

Authors:  Shin-Ru Shih; Mun-Chung Tsai; Sung-Nien Tseng; Kuo-Fang Won; Kak-Shan Shia; Wen-Tai Li; Jyh-Haur Chern; Guang-Wu Chen; Chung-Chi Lee; Yen-Chun Lee; Kuan-Chang Peng; Yu-Sheng Chao
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

8.  Antiviral compounds discovered by virtual screening of small-molecule libraries against dengue virus E protein.

Authors:  Zhigang Zhou; Mansoora Khaliq; Jae-Eun Suk; Chinmay Patkar; Long Li; Richard J Kuhn; Carol Beth Post
Journal:  ACS Chem Biol       Date:  2008-12-19       Impact factor: 5.100

9.  Structure of a human rhinovirus complexed with its receptor molecule.

Authors:  N H Olson; P R Kolatkar; M A Oliveira; R H Cheng; J M Greve; A McClelland; T S Baker; M G Rossmann
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-15       Impact factor: 11.205

Review 10.  Understanding the mechanisms of viral induced asthma: new therapeutic directions.

Authors:  Nicole G Hansbro; Jay C Horvat; Peter A Wark; Philip M Hansbro
Journal:  Pharmacol Ther       Date:  2008-01-29       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.